Nadav Friedmann's Insider Trades & SAST Disclosures
Nadav Friedmann's most recent trade in Cassava Sciences Inc was a trade of 990 Common Stock done . Disclosure was reported to the exchange on Dec. 31, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nadav Friedmann.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 990 | 78,910 (0%) | 0% | 0 | Common Stock | |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 10 | 79,900 (0%) | 0% | 0 | Common Stock | |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 9,376 | 40,624 | - | - | Common Stock | |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.95 per share. | 03 Oct 2022 | 9,376 | 79,910 (0%) | 0% | 0.9 | 8,907 | Common Stock |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2022 | 24,513 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.38 per share. | 27 May 2022 | 24,513 | 95,103 (0%) | 0% | 23.4 | 573,114 | Common Stock |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.66 per share. | 27 May 2022 | 21,498 | 70,534 (0%) | 0% | 26.7 | 573,137 | Common Stock |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.38 per share. | 27 May 2022 | 3,501 | 70,590 (0%) | 0% | 23.4 | 81,853 | Common Stock |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2022 | 3,501 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.66 per share. | 27 May 2022 | 3,071 | 92,032 (0%) | 0% | 26.7 | 81,873 | Common Stock |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2021 | 28,015 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.55 per share. | 17 Mar 2021 | 28,015 | 92,428 (0%) | 0% | 53.5 | 1,500,203 | Common Stock |
| Cassava Sciences Inc | Nadav Friedmann | Director, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.52 per share. | 17 Mar 2021 | 23,996 | 68,429 (0%) | 0% | 62.5 | 1,500,230 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges